UNASSIGNED: A comprehensive literature review analyzed 32 randomized controlled trials (RCTs) retrieved from databases such as PubMed, Cochrane Library, and Google Scholar. The study specifically assessed the incidences of revascularization, stroke, and MI in patients treated with either PCI or CABG. The comparison between CABG and PCI exclusively focused on lesions with a SYNTAX score exceeding 32.
UNASSIGNED: Our findings highlight CABG\'s significant efficacy over PCI in reducing revascularization and MI. The aggregated Mantel-Haenszel (M-H) value for revascularization was 1.85 (95% confidence interval (CI): 1.65 - 2.07), signifying CABG\'s advantage. Additionally, CABG demonstrated superior performance in diminishing MI occurrences (M-H = 2.71, 95% CI: 1.13 - 6.53). In contrast, PCI was more effective in reducing stroke (M-H = 0.80, 95% CI: 0.60 - 1.10).
UNASSIGNED: The study confirms CABG\'s superiority in reducing revascularization and MI in IHD patients, highlighting PCI\'s effectiveness in reducing stroke risk. These findings underscore the importance of personalized treatment strategies in IHD management and emphasize the need for ongoing research and evidence-based guidelines to aid in treatment selection for IHD patients.
■综合文献综述分析了从PubMed等数据库中检索到的32项随机对照试验(RCT),科克伦图书馆,谷歌学者。这项研究特别评估了血运重建的发生率,中风,接受PCI或CABG治疗的患者的MI。CABG和PCI之间的比较仅集中在SYNTAX评分超过32的病变上。
■我们的研究结果强调了CABG在减少血运重建和MI方面优于PCI的显著疗效。血运重建的Mantel-Haenszel(M-H)值是1.85(95%置信区间(CI):1.65-2.07),标志着CABG的优势。此外,CABG在减少MI发生率方面表现优异(M-H=2.71,95%CI:1.13-6.53)。相比之下,PCI在减少卒中方面更有效(M-H=0.80,95%CI:0.60-1.10)。
■该研究证实了CABG在减少IHD患者血运重建和MI方面的优越性,强调PCI在降低卒中风险方面的有效性。这些发现强调了个性化治疗策略在IHD管理中的重要性,并强调需要持续的研究和循证指南来帮助IHD患者的治疗选择。